Ayoub, Isabelle
Nelson, Jessica
Rovin, Brad H.
Funding for this research was provided by:
National Institutes of Health (UL1Tr0001108)
SPARC (CCTS 60047517)
National Cancer Institute (CCSG:P3016058)
Article History
First Online: 14 August 2018
Compliance with Ethical Standards
:
: Dr. Rovin reports grants from National Institutes of Health UL1Tr0001108, grants from SPARC CCTS 60047517, grants from NCI CCSG:P3016058, during the conduct of the study, personal fees and other from Alexion, personal fees and other from Aurinia, non-financial support and other from Biogen, personal fees and other from Chemocentryx, personal fees and other from Genentech, grants from Mallinckrodt, personal fees and other from Biomarin, personal fees and other from BMS, grants from EMD Serono, grants from Lupus Foundation of America, personal fees and other from Pharmalink, personal fees and other from Retrophin, personal fees and other from Rigel, personal fees and other from Ra Pharmaceuticals, and personal fees and other from Novartis, outside the submitted work.Isabelle Ayoub and Jessica Nelson declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.